- Home
- NMRA vs GNT Comparison
NMRA vs GNT Comparison
Compare NMRA & GNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- GNT
- Stock Information
- Founded
- NMRA 2019
- GNT 2011
- Country
- NMRA United States
- GNT United States
- Employees
- NMRA N/A
- GNT N/A
- Industry
- NMRA
- GNT Finance/Investors Services
- Sector
- NMRA
- GNT Finance
- Exchange
- NMRA Nasdaq
- GNT Nasdaq
- Market Cap
- NMRA 121.0M
- GNT 103.9M
- IPO Year
- NMRA 2023
- GNT N/A
- Fundamental
- Price
- NMRA $0.77
- GNT $6.45
- Analyst Decision
- NMRA Buy
- GNT
- Analyst Count
- NMRA 8
- GNT 0
- Target Price
- NMRA $9.29
- GNT N/A
- AVG Volume (30 Days)
- NMRA 847.9K
- GNT 40.9K
- Earning Date
- NMRA 08-05-2025
- GNT 01-01-0001
- Dividend Yield
- NMRA N/A
- GNT 6.61%
- EPS Growth
- NMRA N/A
- GNT N/A
- EPS
- NMRA N/A
- GNT 0.95
- Revenue
- NMRA N/A
- GNT N/A
- Revenue This Year
- NMRA N/A
- GNT N/A
- Revenue Next Year
- NMRA N/A
- GNT N/A
- P/E Ratio
- NMRA N/A
- GNT $5.36
- Revenue Growth
- NMRA N/A
- GNT N/A
- 52 Week Low
- NMRA $0.61
- GNT $4.59
- 52 Week High
- NMRA $17.19
- GNT $5.40
- Technical
- Relative Strength Index (RSI)
- NMRA 45.74
- GNT 61.23
- Support Level
- NMRA $0.81
- GNT $5.97
- Resistance Level
- NMRA $1.34
- GNT $6.45
- Average True Range (ATR)
- NMRA 0.10
- GNT 0.10
- MACD
- NMRA -0.01
- GNT -0.00
- Stochastic Oscillator
- NMRA 12.55
- GNT 55.26
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About GNT GAMCO Natural Resources Gold & Income Trust
GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.